Herbal capsules for treating depression
Part of Mental health clinical trials.
This study tests an herbal capsule (Jieyu Chufan) for treating depression. It compares the capsule to a placebo (a pill with no active ingredient) to see if it helps reduce depressive symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 65 years old.
- You must have a current diagnosis of depression (first episode or a relapse).
- Your depression must be significant, as measured by a standard questionnaire.
- You cannot have taken antidepressants for at least 2 weeks before starting (or 6 weeks if you were on fluoxetine/Prozac).
- You must not have other major mental health conditions (like bipolar disorder or schizophrenia), and you must not be at high risk of suicide.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational medication (CYB003) for people with major depression whose current antidepressant isn't working well enough. It looks at whether this treatment can help improve depression symptoms.
This study tests an investigational drug called KH607 for adults with major depressive disorder (MDD). It aims to see if the drug can reduce depression symptoms over time. Participants must stop other depression medications before starting and will be monitored closely.
This study tests a new antidepressant tablet against an approved one to see which works better and is safer for adults with major depression. It may help find a more effective option for treating depressive symptoms.
This study tests whether a new medication called TNX-102 SL can reduce depression symptoms better than a placebo (inactive pill). You'll take the medication daily and have regular check-ins to see how you're doing.
This study tests whether Shugan Jieyu capsules, a Chinese herbal medicine, can safely and effectively treat depression. It looks at how well the capsules work and any side effects, with the goal of offering an alternative treatment option.
This Phase 3 trial studies Shugan Jieyu Capsule to treat generalized anxiety disorder (GAD). It aims to see if it can reduce anxiety symptoms in people who fit specific anxiety severity and traditional diagnosis criteria.
Hear when a new Major Depressive Disorder (MDD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.